Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024287185> ?p ?o ?g. }
- W2024287185 endingPage "181" @default.
- W2024287185 startingPage "172" @default.
- W2024287185 abstract "The combined effect of rimantadine and oseltamivir in a prophylactic context (therapy beginning 4 h pre-virus infection) and therapeutic context (therapy started at 24 h post-viral inoculation) course on influenza H3N2 virus infection in mice was studied. In the prophylactic course 5 and 10 mg/kg/day rimantadine with 0.2 and 0.4 mg/kg/day (25:1 dose ratio) oseltamivir showed a protection index (PI) of 79.6% and 75%, respectively and a mean survival time (MST) of 13.1 and 12.9 days. The individual effects of the same doses ranged from 0% to 33.3% PI and 8.2 to 10.3 days MST, respectively. Lung virus titers were decreased 630-fold in the combination-treated groups as compared to monotherapy and placebo groups. The reduction of surface lung pathology in combination-treated groups demonstrated a protective effect for the combination of both antivirals. In the therapeutic course 5 and 10 mg/kg rimantadine combined with 0.2 and 0.4 mg/kg oseltamivir showed no beneficial effect. At higher dosage (0.8, 1.6, 3.2 mg/kg oseltamivir and 20, 40, 80 mg/kg rimantadine) preserving the 25:1 ratio, the resultant PI ranged from 57.6% to 80.5% and the MST was 12.8-13.4 days. Used alone at the same doses the compounds' protection varied between 10.7% and 71.8% PI, MST 9.8-12.8 days (8.7 days in PBS control). Compared to vehicle and individual treatment, a decrease in infectious viral titers of up to 1000-fold and other viral pneumonia parameters were also recorded. The therapeutic effect of the drugs' optimal effective doses combinations was characterized as synergistic. Survival of animals was 81.2-100% and MST was extended by 5-7 days compared to placebos. Monotherapy protection was from 9.1% to a maximum of 56.5%, MST being prolonged only by 1.3-4.2 days compared to 7.5 days in the PBS control group. Lung viral titers were decreased 1445-fold for the most efficacious combination groups and a significant reduction in lung parameters was observed. These data emphasize that prophylactic and therapeutic courses using a combination of oseltamivir and rimantadine have a significant protective effect in mice experimentally infected with drug-sensitive influenza virus A (H3N2)." @default.
- W2024287185 created "2016-06-24" @default.
- W2024287185 creator A5002618560 @default.
- W2024287185 creator A5049052342 @default.
- W2024287185 creator A5059888062 @default.
- W2024287185 date "2012-08-01" @default.
- W2024287185 modified "2023-10-10" @default.
- W2024287185 title "Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice" @default.
- W2024287185 cites W134199829 @default.
- W2024287185 cites W1518023766 @default.
- W2024287185 cites W1536496588 @default.
- W2024287185 cites W1766393696 @default.
- W2024287185 cites W1893105611 @default.
- W2024287185 cites W1973199150 @default.
- W2024287185 cites W1973503801 @default.
- W2024287185 cites W1976576877 @default.
- W2024287185 cites W1984468567 @default.
- W2024287185 cites W1992115679 @default.
- W2024287185 cites W1994538071 @default.
- W2024287185 cites W1997343899 @default.
- W2024287185 cites W2001734810 @default.
- W2024287185 cites W2021813652 @default.
- W2024287185 cites W2021827364 @default.
- W2024287185 cites W2029634452 @default.
- W2024287185 cites W2041550368 @default.
- W2024287185 cites W2043580251 @default.
- W2024287185 cites W2052287941 @default.
- W2024287185 cites W2055986785 @default.
- W2024287185 cites W2063295841 @default.
- W2024287185 cites W2066295779 @default.
- W2024287185 cites W2102368840 @default.
- W2024287185 cites W2104397822 @default.
- W2024287185 cites W2104873628 @default.
- W2024287185 cites W2106915811 @default.
- W2024287185 cites W2111155300 @default.
- W2024287185 cites W2128060816 @default.
- W2024287185 cites W2130679801 @default.
- W2024287185 cites W2138198678 @default.
- W2024287185 cites W2149083438 @default.
- W2024287185 cites W2156231263 @default.
- W2024287185 cites W2157177671 @default.
- W2024287185 cites W2162820439 @default.
- W2024287185 cites W2165260654 @default.
- W2024287185 cites W2312463092 @default.
- W2024287185 cites W2336492800 @default.
- W2024287185 cites W2409649694 @default.
- W2024287185 cites W2412876393 @default.
- W2024287185 cites W3165798396 @default.
- W2024287185 cites W94004259 @default.
- W2024287185 doi "https://doi.org/10.1016/j.antiviral.2012.05.004" @default.
- W2024287185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22617756" @default.
- W2024287185 hasPublicationYear "2012" @default.
- W2024287185 type Work @default.
- W2024287185 sameAs 2024287185 @default.
- W2024287185 citedByCount "7" @default.
- W2024287185 countsByYear W20242871852013 @default.
- W2024287185 countsByYear W20242871852014 @default.
- W2024287185 countsByYear W20242871852015 @default.
- W2024287185 countsByYear W20242871852016 @default.
- W2024287185 countsByYear W20242871852017 @default.
- W2024287185 countsByYear W20242871852023 @default.
- W2024287185 crossrefType "journal-article" @default.
- W2024287185 hasAuthorship W2024287185A5002618560 @default.
- W2024287185 hasAuthorship W2024287185A5049052342 @default.
- W2024287185 hasAuthorship W2024287185A5059888062 @default.
- W2024287185 hasConcept C102652120 @default.
- W2024287185 hasConcept C126322002 @default.
- W2024287185 hasConcept C12914427 @default.
- W2024287185 hasConcept C151730666 @default.
- W2024287185 hasConcept C19831878 @default.
- W2024287185 hasConcept C203014093 @default.
- W2024287185 hasConcept C2522874641 @default.
- W2024287185 hasConcept C2776999253 @default.
- W2024287185 hasConcept C2777546802 @default.
- W2024287185 hasConcept C2779134260 @default.
- W2024287185 hasConcept C2779343474 @default.
- W2024287185 hasConcept C2780035454 @default.
- W2024287185 hasConcept C2780374985 @default.
- W2024287185 hasConcept C2780391423 @default.
- W2024287185 hasConcept C3008058167 @default.
- W2024287185 hasConcept C32611913 @default.
- W2024287185 hasConcept C524204448 @default.
- W2024287185 hasConcept C71924100 @default.
- W2024287185 hasConcept C86803240 @default.
- W2024287185 hasConcept C98274493 @default.
- W2024287185 hasConceptScore W2024287185C102652120 @default.
- W2024287185 hasConceptScore W2024287185C126322002 @default.
- W2024287185 hasConceptScore W2024287185C12914427 @default.
- W2024287185 hasConceptScore W2024287185C151730666 @default.
- W2024287185 hasConceptScore W2024287185C19831878 @default.
- W2024287185 hasConceptScore W2024287185C203014093 @default.
- W2024287185 hasConceptScore W2024287185C2522874641 @default.
- W2024287185 hasConceptScore W2024287185C2776999253 @default.
- W2024287185 hasConceptScore W2024287185C2777546802 @default.
- W2024287185 hasConceptScore W2024287185C2779134260 @default.
- W2024287185 hasConceptScore W2024287185C2779343474 @default.
- W2024287185 hasConceptScore W2024287185C2780035454 @default.
- W2024287185 hasConceptScore W2024287185C2780374985 @default.